• Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative NeoplasmRECRUITINGPhase 1NCT05025488
• CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeRECRUITINGPhase 2NCT04493164
• A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell TransplantationRECRUITINGPhase 1NCT04024761
• (Apex) Bezuclastinib in Patients With Advanced Systemic MastocytosisRECRUITINGPhase 2NCT04996875
• Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic MalignanciesRECRUITINGPhase 1NCT07565220
• Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative NeoplasmsRECRUITINGPhase 2NCT04282187
• A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell TransplantationRECRUITINGPhase 2NCT06859424
• Improving Cognitive Function in Older Adults Undergoing Stem Cell TransplantRECRUITINGNCT04898790
• Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity ConditioningRECRUITINGPhase 2NCT06815003
• Allo HSCT Using RIC and PTCy for Hematological DiseasesRECRUITINGPhase 2NCT05805605
• Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.RECRUITINGPhase 1NCT04771572
• Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing ChemotherapyRECRUITINGPhase 1NCT03630991
• Cord Blood Transplant in Adults With Blood CancersRECRUITINGPhase 2NCT05884333
• Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant DisordersRECRUITINGPhase 2NCT04644016
• Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic MalignanciesRECRUITINGPhase 1/Phase 2NCT03471260
• Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)RECRUITINGPhase 2NCT03970096
• Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic DiseasesRECRUITINGPhase 2NCT06013423
• CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell TransplantRECRUITINGPhase 2NCT06059391
• A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell TransplantRECRUITINGPhase 1NCT07020533
• Evaluation of the Pathobiology of CALR-mutated MPN CellsRECRUITINGNCT06480591
• Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a SolutionRECRUITINGNCT06131801
• Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme RegistryRECRUITINGNCT05556928
• Investigation of the Genetics of Hematologic DiseasesRECRUITINGNCT02720679
• Project: Every Child for Younger Patients With CancerRECRUITINGNCT02402244
• I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm PatientsRECRUITINGNCT05842603
• Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized StudyRECRUITINGPhase 2NCT06811233
• Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and CareRECRUITINGNCT05745285
• Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood CancersRECRUITINGPhase 2NCT03589729
• Phase I Trial of Pacritinib in Combination With Venetoclax and Azacitidine for the Treatment of Accelerated and Blast Phase Myeloproliferative NeoplasmsNOT_YET_RECRUITINGPhase 1NCT07679334
• A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic TransplantNOT_YET_RECRUITINGPhase 2NCT07572929
• Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell TransplantNOT_YET_RECRUITINGPhase 2NCT07634536
• Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN NeoplasmsACTIVE_NOT_RECRUITINGPhase 2NCT05732961
• A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell TransplantACTIVE_NOT_RECRUITINGPhase 2NCT03739502

Showing active trials that list “Myeloproliferative Neoplasm” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.